Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile
ChemMedChem · 2026-11-26 · 21 (22)
DOI: 10.1002/cmdc.70542 ↗At a glance
Journal article in ChemMedChem, published online on 2026-11-13. Written by Daniela Navarro-Acosta and 6 co-authors. Institution: Grupo de Investigación Química Cuantica y Téorica, Facultad de Ciencias Exactas y Naturales, Universidad de Cartagena, Cartagena, Colombia. Major MEDLINE topics: Receptor, Cannabinoid, CB2, Cannabinoids, Drug Design, Indoles. 98 references.
Abstract (original language)
The CB2 cannabinoid receptor represents an attractive therapeutic target due to its immunomodulatory relevance and its lack of psychoactive effects. Here, we applied an integrated in silico approach to design and prioritize JWH‐015–derived ligands with improved CB2 affinity and pharmacokinetic properties. Density functional theory calculations (PBE/TZVP/GEN‐A2*) provided global and local reactivity descriptors that were correlated with predicted binding interactions obtained from a consensus docking strategy (AutoDock4, Vina, and Smina). Structural stability and interaction persistence were further assessed by nine 500‐ns molecular dynamics simulations. Among the designed structures, analog 9 exhibited the most persistent and favorable interactions with key CB2 residues throughout the simulations, supporting its suitability as a lead candidate. In contrast, analogs 12 and 20 displayed notably safer biosafety profiles, indicating value as alternative scaffolds for further chemical exploration. These results support the rational design of CB2‐targeted ligands and identify structural features that may guide future synthesis and biological evaluation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Grupo de Investigación Química Cuantica y Téorica, Facultad de Ciencias Exactas y Naturales, Universidad de Cartagena, Cartagena, Colombia.
- Naturals Products Group, Faculty of Pharmaceutical Sciences, University of Cartagena, Cartagena, Colombia.
- Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Ciudad Universitaria, Culiacan, Sinaloa, México.
- Departamento de Química, Universidad de Guadalajara, Guadalajara, Jalisco, México.
ORCID profiles: Daniela Navarro-Acosta, Ricardo Vivas-Reyes, Jhoan H Piermattey-Ditta, Ulises Osuna-Martínez, Sara A Cortes-Llamas, Roberto Flores-Moreno, Jesús A Lara-Cerón
Cite
APA
Navarro-Acosta, D., Vivas-Reyes, R., Piermattey-Ditta, J. H., Osuna-Martínez, U., Cortes-Llamas, S. A., Flores-Moreno, R., & Lara-Cerón, J. A. (2026). Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70542
Vancouver
Navarro-Acosta D, Vivas-Reyes R, Piermattey-Ditta JH, Osuna-Martínez U, Cortes-Llamas SA, Flores-Moreno R, et al. Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70542
BibTeX
@article{NavarroAcosta2026,
author = {Navarro-Acosta, Daniela and Vivas-Reyes, Ricardo and Piermattey-Ditta, Jhoan H and Osuna-Martínez, Ulises and Cortes-Llamas, Sara A and Flores-Moreno, Roberto and Lara-Cerón, Jesús A},
title = {Computational Design and In Silico Evaluation of Novel Cannabinoids Targeting the CB2 Receptor: Chemical Reactivity, Binding Mode, and Predicted ADMET Profile},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {22},
doi = {10.1002/cmdc.70542}
}
EUVIMED